Tomita Y - Search Results

1

E-cadherin expression in renal cell cancer and its significance in metastasis and survival.

Katagiri A, Watanabe R, Tomita Y. Katagiri A, et al. Among authors: tomita y. Br J Cancer. 1995 Feb;71(2):376-9. doi: 10.1038/bjc.1995.76. Br J Cancer. 1995. PMID: 7841055 Free PMC article.

2

Immunohistochemical detection of P-glycoprotein and GSTP1-1 in testis cancer.

Katagiri A, Tomita Y, Nishiyama T, Kimura M, Sato S. Katagiri A, et al. Among authors: tomita y. Br J Cancer. 1993 Jul;68(1):125-9. doi: 10.1038/bjc.1993.299. Br J Cancer. 1993. PMID: 8100442 Free PMC article.

3

Loss of human E-cadherin (ECD) correlated with invasiveness of transitional cell cancer in the renal pelvis, ureter and urinary bladder.

Wakatsuki S, Watanabe R, Saito K, Saito T, Katagiri A, Sato S, Tomita Y. Wakatsuki S, et al. Among authors: tomita y. Cancer Lett. 1996 May 15;103(1):11-7. doi: 10.1016/0304-3835(96)04194-8. Cancer Lett. 1996. PMID: 8616803

4

[Significance of lymphadenectomy in renal cancer].

Katagiri A, Tomita Y, Takahashi K. Katagiri A, et al. Among authors: tomita y. Nihon Hinyokika Gakkai Zasshi. 1998 Aug;89(8):721-5. doi: 10.5980/jpnjurol1989.89.721. Nihon Hinyokika Gakkai Zasshi. 1998. PMID: 9780657 Free article. Japanese.

5

Significance of serum-soluble CD95 (Fas/APO-1) on prognosis in renal cell cancer patients.

Kimura M, Tomita Y, Imai T, Saito T, Katagiri A, Tanikawa T, Takeda M, Takahashi K. Kimura M, et al. Among authors: tomita y. Br J Cancer. 1999 Jul;80(10):1648-51. doi: 10.1038/sj.bjc.6690576. Br J Cancer. 1999. PMID: 10408413 Free PMC article.

6

Altered expression of beta-catenin in renal cell cancer and transitional cell cancer with the absence of beta-catenin gene mutations.

Bilim V, Kawasaki T, Katagiri A, Wakatsuki S, Takahashi K, Tomita Y. Bilim V, et al. Among authors: tomita y. Clin Cancer Res. 2000 Feb;6(2):460-6. Clin Cancer Res. 2000. PMID: 10690524

7

Expression of E-cadherin and catenins on testis tumor.

Saito T, Katagiri A, Watanabe R, Tanikawa T, Kawasaki T, Tomita Y, Takahashi K. Saito T, et al. Among authors: tomita y. Urol Int. 2000;65(3):140-3. doi: 10.1159/000064859. Urol Int. 2000. PMID: 11054031

8

Significance of serum amyloid A on the prognosis in patients with renal cell carcinoma.

Kimura M, Tomita Y, Imai T, Saito T, Katagiri A, Ohara-Mikami Y, Matsudo T, Takahashi K. Kimura M, et al. Among authors: tomita y. Cancer. 2001 Oct 15;92(8):2072-5. doi: 10.1002/1097-0142(20011015)92:8<2072::aid-cncr1547>3.0.co;2-p. Cancer. 2001. PMID: 11596022

9

Correlation of p53 protein expression in human urothelial transitional cell cancers with malignant potential and patient survival.

Watanabe R, Tomita Y, Nishiyama T, Tanikawa T, Sato S. Watanabe R, et al. Among authors: tomita y. Int J Urol. 1994 Mar;1(1):43-8. doi: 10.1111/j.1442-2042.1994.tb00007.x. Int J Urol. 1994. PMID: 7627837 Free article.

10

Interferon-alpha-induced protection of renal cell cancer cell line from lysis by natural killer cells and increase of susceptibility by treatment with 5-fluorouracil.

Imai T, Katagiri A, Saito K, Tomita Y. Imai T, et al. Among authors: tomita y. Cancer Lett. 1995 Aug 1;94(2):191-7. doi: 10.1016/0304-3835(95)03849-r. Cancer Lett. 1995. PMID: 7634247

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,554 results

Search Page

Filters